4//SEC Filing
DeSimone Jill 4
Accession 0000950170-24-028264
CIK 0001808865other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 8:01 PM ET
Size
5.4 KB
Accession
0000950170-24-028264
Insider Transaction Report
Form 4
DeSimone Jill
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-03-07+44,766→ 44,766 totalExercise: $11.58Exp: 2034-03-07→ Common Stock (44,766 underlying)
Footnotes (1)
- [F1]This stock option shall vest over 3 years, with 1/3 vesting on March 7, 2025, and thereafter in equal monthly installments over the next 24 months, subject to the Reporting Person's continued service as a director through the applicable vesting date.
Documents
Issuer
iTeos Therapeutics, Inc.
CIK 0001808865
Entity typeother
Related Parties
1- filerCIK 0001930479
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 8:01 PM ET
- Size
- 5.4 KB